Alcohol and Cancer: The Risk Most Drinkers Do Not Know About

Alcohol is a carcinogen - this is not disputed

The International Agency for Research on Cancer (IARC), part of the World Health Organisation, classifies alcoholic beverages as a Group 1 carcinogen. Group 1 means there is sufficient evidence that the substance causes cancer in humans. It puts alcohol in the same category as tobacco, asbestos, and processed meat.

This classification is not new. IARC first classified alcohol as a Group 1 carcinogen in 1988. The evidence has only grown stronger since then. Yet surveys consistently show that the majority of people who drink regularly - including heavy drinkers - are unaware that alcohol causes cancer.

This gap between scientific consensus and public awareness is significant. Part of it reflects the sustained efforts of the alcohol industry to fund research casting doubt on the relationship, in a pattern that mirrors the tobacco industry's strategy in the decades following the first evidence linking cigarettes to lung cancer. Part of it reflects the normalisation of alcohol in social life. And part of it reflects a genuine failure of public health communication. For people struggling with alcohol use disorder, understanding the cancer risk is one important piece of the case for seeking treatment.

Which cancers does alcohol cause?

The evidence is strongest - meaning the causal relationship is most clearly established - for the following seven cancer types:

• Mouth and throat (oral cavity and pharynx)
• Oesophagus
• Larynx (voice box)
• Liver
• Colon and rectum (colorectal)
• Breast (in women)
• Stomach (evidence somewhat less definitive but included in most major reviews)

Of these, colorectal cancer and breast cancer are particularly significant in terms of population burden, because these are common cancers in the populations where alcohol consumption is highest.

There is also growing evidence for a link between alcohol and pancreatic cancer, though the evidence is not yet as strong as for the cancers listed above.

The dose-response relationship: is there a safe level?

One of the most important - and for many people, most uncomfortable - findings from the alcohol and cancer research is that there does not appear to be a threshold below which alcohol consumption carries no increased cancer risk. The relationship between alcohol and cancer appears to be dose-dependent: more alcohol, more risk; but some risk exists even at low levels of consumption.

A 2018 analysis published in The Lancet, drawing on data from 195 countries, concluded that "the safest level of drinking is none." This has become one of the most widely cited findings in the field, and it has driven the revision of national drinking guidelines in several countries - Canada updated its guidelines in 2023 to state explicitly that there is no safe amount of alcohol from a cancer perspective.

The dose-response relationship is most clearly established for breast cancer. Even one drink per day increases breast cancer risk by approximately 7 to 10 percent relative to non-drinkers. This risk increases with each additional drink. For women who drink two to three drinks daily, breast cancer risk is approximately 20 percent higher than for non-drinkers. Research from the National Institute on Alcohol Abuse and Alcoholism confirms this dose-dependent pattern across multiple cancer types.

For upper gastrointestinal cancers (mouth, throat, oesophagus), the risk is substantially elevated at heavier drinking levels, and the combination of alcohol and tobacco is synergistic - the combined risk from both is significantly greater than the sum of the individual risks. Stopping drinking helps reduce this combined risk, and medically supervised alcohol withdrawal can make the process safer for those with alcohol use disorder.

Why alcohol's cancer risk is underappreciated

Several factors explain the persistent gap between the evidence on alcohol and cancer and public awareness of it.

The alcohol industry has invested substantially in research programmes designed to obscure or minimise the cancer link. A 2020 analysis of industry-funded research found systematic bias toward findings that downplayed alcohol's risks and highlighted purported benefits. This mirrors the tobacco playbook of funding doubt rather than accepting scientific consensus.

The earlier emphasis on cardiovascular benefits of moderate drinking also played a role. The narrative that a glass of red wine was good for the heart - heavily promoted from the 1990s onward - established alcohol as a nuanced rather than simply harmful substance in public consciousness. More recent research has substantially revised this picture: the apparent cardiovascular benefits of moderate drinking appear to be largely or entirely explained by methodological problems in the observational studies that identified them (particularly the "sick quitter" bias, where people who stopped drinking due to illness were classified as abstainers, making moderate drinkers look healthier by comparison).

The long latency period between exposure and cancer is also a factor. Cancers that develop over decades feel disconnected from the daily behaviour that contributes to them in a way that, for example, a hangover does not. The feedback loop is too slow to generate the visceral awareness that drives behaviour change.

What reducing or stopping drinking means for cancer risk

The good news - and it is significant - is that the cancer risk associated with alcohol is largely reversible with sustained abstinence or substantial reduction in consumption.

For most alcohol-related cancers, risk begins to decline after stopping drinking, and approaches (though does not fully reach) the risk level of lifetime abstainers over a period of years to decades. The reduction is greatest for upper gastrointestinal cancers and somewhat slower for breast cancer.

This means that stopping drinking in your 40s or 50s, after a period of heavy use, still produces meaningful reductions in cancer risk over the following years. The decision is not all-or-nothing in terms of benefit. Every year of abstinence reduces accumulated risk.

For people with alcohol dependence who are seeking treatment, the cancer risk reduction is one of several powerful medical arguments for achieving and maintaining sobriety - alongside liver disease, cardiovascular disease, neurological damage, and the well-documented impacts on mental health.

Having the conversation

Many people with alcohol use disorder have not had an explicit conversation with their doctor about the cancer risks associated with their drinking. This is partly because the consultation time required for a thorough discussion is often not available in primary care settings, and partly because raising cancer risk can feel stigmatising in a way that GPs may want to avoid.

If you are drinking at levels you suspect may be harmful, asking directly about cancer risk is appropriate. The evidence is clear and your doctor should be able to provide it. And if the conversation leads to a discussion about treatment options - whether that is brief intervention, medication, or referral to an alcohol treatment programme - that is the conversation that most needs to happen.

About the author

Christopher Murray

Dip.C.Hyp · HPD · NLP · MNCH

Christopher Murray is a cognitive hypnotherapist, NLP practitioner, and author of The Confidence Reset. Co-founder of the Sansun Group, he works with high-functioning individuals internationally and advises families and clients navigating addiction treatment and rehabilitation across Asia.

chrismurrayhypnosis.com confidenceresetnow.com